Apoptosis Suppression by Candidate Oncogene PLAC8 is Reversed in Other Cell Types

E-ISSN： 1873-5576|13|1|80-91

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.13, Iss.1, 2013-01, pp. : 80-91

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oncogene Suppression by Small Interfering RNAs

Current Pharmaceutical Biotechnology, Vol. 5, Iss. 4, 2004-08 ,pp. : 349-354

Bentham Science Publishers

Access to resources Recommend Favorite

EGFRvIII: an oncogene deletion mutant cell surface receptor target expressed by multiple tumour types

By Wikstrand C.J. Sampson J.H. Bigner D.D.

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 4, 2000-08 ,pp. : 497-514

Informa Healthcare

Access to resources Recommend Favorite

The Selective CXCR2 Antagonist SB272844 Blocks Interleukin-8 and Growth-related Oncogene-α-mediated Inhibition of Spontaneous Neutrophil Apoptosis

By Glynn P.C. Henney E. Hall I.P.

Pulmonary Pharmacology & Therapeutics, Vol. 15, Iss. 2, 2002-05 ,pp. : 103-111

Academic Press

Access to resources Recommend Favorite

Apoptosis: Mediator Molecules, Interplay with Other Cell Death Processes and Therapeutic Potentials

Current Pharmaceutical Biotechnology, Vol. 19, Iss. 8, 2018-07 ,pp. : 644-663

Bentham Science Publishers

Access to resources Recommend Favorite

CD8+ T-cell-mediated Non-cytolytic Suppression of Human Immunodeficiency Viruses

Current Drug Targets - Infectious Disorders, Vol. 3, Iss. 2, 2003-06 ,pp. : 97-113

Bentham Science Publishers

Access to resources Recommend Favorite